Lobbying disclosures · Lobbying report
GILD: second_quarter 2026 lobbying report
Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals. Legislative and regulatory proposals to change international and domestic corporate tax law and policy. Advocate on domestic and global drug pricing proposals, international trade and protection
Follow GILD- Became public
- Jul 20, 2026, 5:19 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 2:18 PM EST
Why this is connected
Exact legal-name match: GILEAD SCIENCES, INC. (https://www.sec.gov/Archives/edgar/data/882095/).
Reported lobbying amounts
Expenses: $1,590,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/c4563d15-16ce-4e93-97ee-783fd860070a/","filing_uuid":"c4563d15-16ce-4e93-97ee-783fd860070a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c4563d15-16ce-4e93-97ee-783fd860070a/print/","filing_document_content_type":"text/html","income":null,"expenses":"1590000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Boyd","dt_posted":"2026-07-20T17:19:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"333 LAKESIDE DRIVE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"FOSTER CITY","registrant_state":"CA","registrant_zip":"94404","registrant":{"id":287177,"url":"https://lda.gov/api/v1/registrants/287177/","house_registrant_id":37026,"name":"GILEAD SCIENCES, INC.","description":null,"address_1":"333 LAKESIDE DRIVE","address_2":null,"address_3":null,"address_4":null,"city":"FOSTER CITY","state":"CA","state_display":"California","zip":"94404","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABIGAIL STRAYER","contact_telephone":"+1 240-619-9258","dt_updated":"2026-07-29T14:24:27.706440-04:00"},"client":{"id":176597,"url":"https://lda.gov/api/v1/clients/176597/","client_id":12,"name":"GILEAD SCIENCES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150959,"prefix":null,"prefix_display":null,"first_name":"RILEY","nickname":null,"middle_name":null,"last_name":"SWINEHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Legislative and regulatory proposals to change international and domestic corporate tax law and policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Advocate on domestic and global drug pricing proposals, international trade and protection of intellectual property; global supply chain issues, including the Medical Supply Chain Resiliency Act and tariffs; compulsory licensing and other IP issues in multiple countries.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71381,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"D","last_name":"BOYD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150959,"prefix":null,"prefix_display":null,"first_name":"RILEY","nickname":null,"middle_name":null,"last_name":"SWINEHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocate on drug pricing proposals. Proposals to expand access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Issues related to triple negative breast cancer (TNBC) and early detection and screenings for breast cancer. Advocate in favor of 340B program reforms and changes. Issues related to developing treatments and therapies, including: manufacturing, clinical trials, reimbursement and coverage.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71381,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"D","last_name":"BOYD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73330,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150959,"prefix":null,"prefix_display":null,"first_name":"RILEY","nickname":null,"middle_name":null,"last_name":"SWINEHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocate for provisions modifying the Inflation Reduction Act and other drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, oncology products, and COVID-19 therapies and prevention including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules, including those related to payments in Medicare, Medicaid drug rebates, and proposed CMMI demonstrations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71381,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"D","last_name":"BOYD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73330,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150959,"prefix":null,"prefix_display":null,"first_name":"RILEY","nickname":null,"middle_name":null,"last_name":"SWINEHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in GILD
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026
- Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026 · Dependent
- Feb 26, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jan 27, 2026 · disclosed Feb 26, 2026 · Joint
- Oct 10, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Sep 23, 2025 · disclosed Oct 10, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 12, 2025 · disclosed Jun 22, 2025
- Jun 18, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Jun 6, 2025 · disclosed Jun 18, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.